van de Vosse et al. Antisense-mediated exon skipping to correct IL-12Rβ1 deficiency in T cells. Blood. 2009;113(19):4548–4555.

On pages 4548 and 4555 of the May 7, 2009, issue, the contribution by 3 authors (Gerard J. Platenburg, Judith C. T. van Deutekom, and Annemieke Aartsma-Rus) was omitted. On page 4555, the Acknowledgments have been removed. The correct byline, affiliations list, and Authorship contribution are listed below. The errors were corrected in the online version, which now differs from the print version.

Esther van de Vosse,¹ Els M. Verhard,¹ Roelof A. de Paus,¹ Gerard J. Platenburg,² Judith C. T. van Deutekom,^2,3 Annemieke Aartsma-Rus,³ and Jaap T.van Dissel¹

¹Department of Infectious Diseases, Leiden University Medical Center, Leiden; ²Prosensa Therapeutics BV, Leiden; and ³Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

Contribution: E.v.d.V. designed the research, analyzed data, and wrote the paper; J.T.v.D. designed the research; E.M.V. and R.A.d.P. performed the research; and G.J.P., J.C.T.v.D., and A.A.-R. designed AONs and advised on exon skip techniques.